Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #9,011 to #9,060.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Gerdy's tubercle [266 bytes]
  2. (hist) Auxiliary cell [266 bytes]
  3. (hist) TransMolecular [266 bytes]
  4. (hist) Melanotroph [266 bytes]
  5. (hist) Structural heart disease [266 bytes]
  6. (hist) Tabes Dorsalis future or investigational therapies [266 bytes]
  7. (hist) Hypersensitivity pneumonitis chest x ray [266 bytes]
  8. (hist) Left ventricular hypertrophy classification [266 bytes]
  9. (hist) Left ventricular hypertrophy pathophysiology [266 bytes]
  10. (hist) Left ventricular hypertrophy epidemiology and demographics [266 bytes]
  11. (hist) Left ventricular hypertrophy risk factors [266 bytes]
  12. (hist) Left ventricular hypertrophy screening [266 bytes]
  13. (hist) Left ventricular hypertrophy history and symptoms [266 bytes]
  14. (hist) Left ventricular hypertrophy physical examination [266 bytes]
  15. (hist) Left ventricular hypertrophy laboratory findings [266 bytes]
  16. (hist) Left ventricular hypertrophy CT [266 bytes]
  17. (hist) Left ventricular hypertrophy MRI [266 bytes]
  18. (hist) Left ventricular hypertrophy other imaging findings [266 bytes]
  19. (hist) Left ventricular hypertrophy other diagnostic studies [266 bytes]
  20. (hist) Left ventricular hypertrophy medical therapy [266 bytes]
  21. (hist) Left ventricular hypertrophy surgery [266 bytes]
  22. (hist) Left ventricular hypertrophy primary prevention [266 bytes]
  23. (hist) Left ventricular hypertrophy secondary prevention [266 bytes]
  24. (hist) Left ventricular hypertrophy future or investigational therapies [266 bytes]
  25. (hist) Left ventricular hypertrophy case study one [266 bytes]
  26. (hist) Bradycardia cost-effectiveness of therapy [266 bytes]
  27. (hist) Hypersensitivity pneumonitis electrocardiogram [266 bytes]
  28. (hist) Hernia secondary prevention [266 bytes]
  29. (hist) Hypogonadism other imaging findings [266 bytes]
  30. (hist) Metabolic syndrome cost-effectiveness of therapy [266 bytes]
  31. (hist) Hyperandrogenism risk factors [266 bytes]
  32. (hist) Diabetes insipidus case study one [266 bytes]
  33. (hist) Plasma cell neoplasm historical perspective [266 bytes]
  34. (hist) Plasma cell neoplasm screening [266 bytes]
  35. (hist) Plasma cell neoplasm electrocardiogram [266 bytes]
  36. (hist) Plasma cell neoplasm chest x ray [266 bytes]
  37. (hist) Plasma cell neoplasm echocardiography or ultrasound [266 bytes]
  38. (hist) Plasma cell neoplasm primary prevention [266 bytes]
  39. (hist) Plasma cell neoplasm secondary prevention [266 bytes]
  40. (hist) Plasma cell neoplasm cost-effectiveness of therapy [266 bytes]
  41. (hist) X-linked agammaglobulinemia natural history, complications and prognosis [266 bytes]
  42. (hist) Upper respiratory tract infection pathophysiology [266 bytes]
  43. (hist) Upper respiratory tract infection historical perspective [266 bytes]
  44. (hist) Upper respiratory tract infection differential diagnosis [266 bytes]
  45. (hist) Upper respiratory tract infection physical examination [266 bytes]
  46. (hist) Upper respiratory tract infection case study one [266 bytes]
  47. (hist) Hepatorenal syndrome cost-effectiveness of therapy [266 bytes]
  48. (hist) Polydipsia classification [266 bytes]
  49. (hist) Polydipsia pathophysiology [266 bytes]
  50. (hist) Polydipsia polydipsia in psychiatric patients [266 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)